News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Brady Stephen R
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/13/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/15/2023 |
4
| Brady Stephen R (Director) has filed a Form 4 on Atreca, Inc.|
Txns:
| Granted 12,000 options to buy
@ $1.18, valued at
$14.2k
|
|
| 01/05/2023 |
4
| Brady Stephen R (CEO) has filed a Form 4 on Tempest Therapeutics, Inc.|
Txns:
| Granted 177,300 options to buy
@ $1.23, valued at
$218.1k
|
|
| 06/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/06/2022 |
4
| Brady Stephen R (CEO) has filed a Form 4 on Tempest Therapeutics, Inc.|
Txns:
| Granted 94,500 options to buy
@ $5.45, valued at
$515k
|
|
| 07/16/2021 |
4
| Brady Stephen R (Director) has filed a Form 4 on Atreca, Inc.|
Txns:
| Granted 24,000 options to buy
@ $7.95, valued at
$190.8k
|
|
| 07/16/2021 |
3
| Brady Stephen R (Director) has filed a Form 3 on Atreca, Inc. |
| 06/29/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/29/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 04/04/2019 |
4
| Brady Stephen R (EVP, Strategy & Finance) has filed a Form 4 on IMMUNE DESIGN CORP.|
Txns:
| Disposed/sold 17,063 shares
@ $5.85, valued at
$99.8k
Disposed/sold 79,536 restricted stock units
@ $0
Disposed/sold 116,819 options to buy
@ $1.23, valued at
$143.7k
Disposed/sold 100,000 options to buy
@ $4.05, valued at
$405k
Disposed/sold 184,364 options to buy
@ $4.4, valued at
$811.2k
Disposed/sold 120,000 options to buy
@ $1.31, valued at
$157.2k
|
|
| 01/07/2019 |
4
| Brady Stephen R (EVP, Strategy & Finance) has filed a Form 4 on IMMUNE DESIGN CORP.|
Txns:
| Granted 25,000 shares
@ $0
Sold 5,516 shares
@ $1.5812, valued at
$8.7k
Granted 120,000 options to buy
@ $1.31, valued at
$157.2k
|
|
| 11/09/2018 |
4
| Brady Stephen R (EVP, Strategy & Finance) has filed a Form 4 on IMMUNE DESIGN CORP.|
Txns:
| Granted 29,953 shares
@ $0 |
|
| 07/19/2018 |
4
| Brady Stephen R (EVP, Strategy & Finance) has filed a Form 4 on IMMUNE DESIGN CORP.|
Txns:
| Disposed/sold 27,525 options to buy
@ $8.92, valued at
$245.5k
Granted 18,350 options to buy
@ $4.4, valued at
$80.7k
Disposed/sold 12,230 options to buy
@ $8.92, valued at
$109.1k
Granted 8,154 options to buy
@ $4.4, valued at
$35.9k
Disposed/sold 2,838 options to buy
@ $31, valued at
$88k
Granted 1,419 options to buy
@ $4.4, valued at
$6.2k
Disposed/sold 47,162 options to buy
@ $31, valued at
$1.5M
Granted 23,581 options to buy
@ $4.4, valued at
$103.8k
Disposed/sold 50,000 options to buy
@ $13, valued at
$650k
Granted 33,334 options to buy
@ $4.4, valued at
$146.7k
Disposed/sold 5,054 options to buy
@ $19.39, valued at
$98k
|
|
| 01/08/2018 |
4
| Brady Stephen R (EVP, Strategy & Finance) has filed a Form 4 on Immune Design Corp.|
Txns:
| Granted 20,000 shares
@ $0
Sold 3,328 shares
@ $4.1721, valued at
$13.9k
Granted 100,000 options to buy
@ $4.05, valued at
$405k
|
|
| 01/06/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 07/19/2016 |
4
| Brady Stephen R (EVP, Strategy & Finance) has filed a Form 4 on Immune Design Corp.|
Txns:
| Bought 1,500 shares
@ $6.8369, valued at
$10.3k
|
|
|
|